Eisai Teams With Accenture In India For Clinical Data Management
This article was originally published in PharmAsia News
Following the growing trend of outsourcing primary operational functions, Eisai announced Feb. 13 a collaborative effort with Accenture to manage Eisai's Japan, U.S., and European Union clinical data from Accenture's Chennai, India-based delivery center
You may also be interested in...
TOKYO - To curb soaring worldwide research and development costs, pharmaceutical companies need to outsource "basically anything that can be pushed down the fiber optic cable," including clinical data management, Ron Fitzmartin, vice president, Informatics and Knowledge Management for New Jersey-based Daiichi Sankyo Pharma Development, told a Drug Information Association conference
NEW DELHI - Faced with margin pressures elsewhere, pharmaceutical multinationals have been eyeing the burgeoning Indian market ever since the country signed the Trade-Related Aspects of Intellectual Property Rights pact. Initially hesitant, Japanese pharma companies are now following in the footsteps of Western companies, using India as a hub for low-cost contract manufacturing and clinical trials
Bristol-Myers Squibb and Accenture have established a center for pharmacovigilance as part of Accenture's Life Sciences Centers of Excellence in Chennai, India, Accenture announced Sept. 13